J. D. Baumgartner

Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon-  in the Serum of Patients with Septic Shock

Thierry Calandra, J. D. Baumgartner, Georges E. Grau et al. · The Journal of Infectious Diseases · 1990 · 552 citations · Full text

Inflammation, Cytokine, Prognostic Biomarkers +14

Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide

Gláucia Zanetti, Didier Heumann, J. Gérain et al. · The Journal of Immunology · 1992 · 247 citations · Full text

Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes

Didier Heumann, Philippe Gallay, C Barras et al. · The Journal of Immunology · 1992 · 213 citations

Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients

Alain Cometta, J. D. Baumgartner, Daniel Lew et al. · Antimicrobial Agents and Chemotherapy · 1994 · 204 citations · Full text

Severe Infections, Health Sciences, Antibiotics +14

Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies.

J. D. Baumgartner, Didier Heumann, J. Gérain et al. · The Journal of Experimental Medicine · 1990 · 150 citations · Full text

Core Lps, Laboratory Immunology, Immunology +18